Please assess the completion status of the following clinical trial:

Trial Title: Pilot Study of the Contour Neurovascular SystemTM

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Age 18-80 years at screening~2. Unruptured saccular IA in the anterior or posterior circulation with dimensions consistent with Table 2~3. IA appears suitable for Contour Neurovascular SystemTM device Patient has the necessary mental capacity to participate and is willing and able to participate in the study for the duration of the study follow-up and is able to comply with study requirements Patient able to understand and sign a study-specific informed consent form~Exclusion Criteria:~1. Ruptured IA~2. Any other IA that requires treatment in the next year~3. IA width \>8.5 or \<2 mm~4. IA neck \>8 or \<2 mm~5. IA minimum height \<4mm~6. IA embolisation would most likely cause stroke~7. Target IA contains other devices/implants (e.g., coils)~8. Inability to access the target IA with the microcatheter~9. Any congenital or iatrogenic coagulopathy~10. Platelet count \<50,000/microliter~11. Known allergy to platinum, nickel or titanium~12. Known allergy to contrast agents~13. Stenosis of the target IA's parent vessel \>50%~14. Taking daily aspirin or other platelet inhibitor (clopidogrel or equivalent) other than for the target aneurysm~15. Taking any anticoagulants (e.g., warfarin)~16. Abnormal clotting parameters~17. Pregnant, breastfeeding or planning pregnancy in the next 2 years~18. Other medical conditions that could increase the risk of neurovascular procedures (e.g., liver failure, cancer, etc.) or ability to comply with study requirements Participating in another study with investigational devices or drugs

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Contour Neurovascular System placement (Type: EXPERIMENTAL): Treatment of intracranial aneurysm with the Contour Neurovascular System device.

Based on this trial design, predict the completion outcome and termination type (if applicable).